The risk of transmitting prion disease by blood or plasma products.

Various experimental studies have shown infectivity in blood in relation to bovine spongiform encephalitis (BSE) and variant Creutzfeldt-Jakob disease (vCJD). Human to human transmission vCJD infection has been reported via transfusion of non-leukocyte-reduced red cells and, probably, via factor VIII concentrates. A number of precautionary measures are in place but uncertainties remain, especially concerning the number of BSE-infected people in the population. Additional measures such as prion filtration need consideration.

[1]  J Mackenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[2]  E. Rodriguez-Merchan,et al.  Radioactive synoviorthesis for the treatment of haemophilic synovitis , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  R. Will,et al.  Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study , 2006, BMJ.

[4]  P. Brown.  Transmissible spongiform encephalopathy in the 21st century , 2008, Neurology.

[5]  J. Ironside,et al.  Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey , 2009, BMJ : British Medical Journal.

[6]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[7]  P. Brown.  Creutzfeldt‐Jakob disease: reflections on the risk from blood product therapy , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  A. Molesworth,et al.  Variant Creutzfeldt‐Jakob disease and exposure to fractionated plasma products , 2009, Vox sanguinis.

[9]  J. Ironside,et al.  Predicting susceptibility and incubation time of human-to-human transmission of vCJD , 2005, The Lancet Neurology.

[10]  Peter Rudge,et al.  Variant CJD in an individual heterozygous for PRNP codon 129 , 2009, The Lancet.

[11]  Paul Clarke,et al.  Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility , 2005, Journal of The Royal Society Interface.

[12]  R. Knight.  The Relationship between New Variant Creutzfeldt–Jakob Disease and Bovine Spongiform Encephalopathy , 1999, Vox Sanguinis.

[13]  Mark Penney,et al.  Prevalence of lymphoreticular prion protein accumulation in UK tissue samples , 2004, The Journal of pathology.

[14]  S. Prusiner,et al.  Prion biology and diseases. , 1999, Harvey lectures.

[15]  O. Simell,et al.  The normal population distribution of PRNP codon 129 polymorphism , 2003, Acta neurologica Scandinavica.

[16]  N. Hunter,et al.  Transmission of BSE by blood transfusion in sheep , 2000, The Lancet.

[17]  M. Turner,et al.  Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products , 2006, British journal of haematology.

[18]  M. Head,et al.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004, The Lancet.

[19]  N. Hunter,et al.  Prion diseases are efficiently transmitted by blood transfusion in sheep. , 2008, Blood.

[20]  L. McShane,et al.  Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt‐Jakob disease in humans , 1999, Transfusion.

[21]  R. Carbonell,et al.  Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins , 2006, The Lancet.

[22]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[23]  N. Hunter,et al.  Transmission of prion diseases by blood transfusion. , 2002, The Journal of general virology.

[24]  S. Love,et al.  Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[25]  Antonio Giulivi,et al.  Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood , 2004, The Lancet.

[26]  Suvankar Pal,et al.  Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report , 2006, The Lancet.

[27]  P. Brown,et al.  The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy , 1998, Transfusion.